Scintigraphic evaluation of multifocal osteolytic lesions in a patient with primary hyperparathyroidism: A case report

Document Type : Case Report


Institute of Pathophysiology and Nuclear Medicine, “Acad. Isak S. Tadzer”, Medical Faculty, University of “Ss Cyril and Methodius”, Skopje, R. Macedonia


Osteitis fibrosa cystica is the classic patognomonic form of skeletal disease in hyperparathyroidism that characterizes with decreased cortical bone thickness compared to increased cancellous bone. We present a case of 52-year old female patient with osteolysis of the left calf on radiographic images. The bone scan detected multiple focal pathological accumulations in the skull, left tibia, both femurs and in the left ischium. The scan was indicative of secondary multiple skeletal metastases. Because the patient had no previous history of primary malignant disease, metabolic bone disease was suspected and also confirmed after i.v application of 99mTc-MIBI. The scan was in favor of parathyroid adenoma with bone complication (osteitis fibrosa cystica). Neck ultrasonography revealed hypoechoic oval mass below the left lower thyroid lobe that suggested the possibility of parathyroid adenoma. An increased ionized calcium level and PTH confirmed the diagnosis of primary hyperparathyroidism. Parathyroidectomy with radioguided surgery was performed. Hyperparathyroidism is a curable disease and a clinician should always bear in mind a metabolic bone disease when performing a nuclear bone scan where multiple bone lesions are detected (a hallmark of metastatic disease).


Main Subjects

Moe SM. Disorders Involving Calcium, Phosphorus, and Magnesium. Prim Care. 2008 Jun; 35(2): 215–vi.
Mazzaglia PJ, Berber E, Kovach A, Milas M, Esselstyn C, Siperstein AE. The changing presentation of hyperparathyroidism over 3 decades. Arch Surg. 2008 Mar;143(3):260-6.
Maina AM, Kraus H. Successful treatment of osteitis fibrosa cystica from primary hyperparathyroidism. Case Rep Orthop. 2012;2012:145760.
Eufrazino C, Veras A, Bandeira F. Epidemiology of Primary Hyperparathyroidism and its Non-classical Manifestations in the City of Recife, Brazil. Clin Med Insights Endocrinol Diabetes. 2013 Dec 4;6:69-74.
Imaging in primary hyperparathyroidism.  Available from:
Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res. 2002 Nov;17 Suppl 2:N18-23.
Bilezikian JP. Primary hyperparathyroidism. In: Singer F. Diseases of bone and mineral metabolism. Available from:
Marx SJ. Hyperparathyroid genes: sequences reveal answers and questions. Endocr Pract. 2011 Jul-Aug;17 Suppl 3:18-27.
Silverberg SJ, Bilezikian JP, Bone HG, Talpos GB, Horwitz MJ, Stewart AF. Therapeutic controversies in primary hyperparathyroidism. J Clin Endocrinol Metab. 1999 Jul;84(7):2275-85.
Lloyd RV. Endocrine pathology: differential diagnosis and molecular advances. 2nd ed. Springer; 2010.
Rubin MR, Livolsi VA, Bandeira F, Caldas G, Bilezikian JP. Tc99m-sestamibi uptake in osteitis fibrosa cystica simulating metastatic bone disease. J Clin Endocrinol Metab. 2001 Nov;86(11):5138-41.
Mellors RC. Bone. Available from:
Rosenberg EH, Guralnick WC. Hyperparathyroidism. A review of 220 proved cases, with special emphasis on findings in the jaws. Oral Surg Oral Med Oral Pathol. 1962;15:84–94.
Verlaan L, van der Wal B, de Maat GJ, Walenkamp G, Nollen-Lopez L, van Ooij A. Primary hyperparathyroidism and pathological fractures: a review. Acta Orthop Belg. 2007 Jun;73(3):300-5.
Hamdi Sahan M, Guner S, Ilkay Guner S. Radiological findings in the primary hyperparathyroid case with multiple brown tumors: a case report. Eastern J Med. 2008;13:30–34.
Kocher MS, Gebhardt MC, Jaramillo D, Perez-Atayde AR. Multiple lytic skeletal lesions and hypercalcemia in a 13-year-old girl. Clin Orthop Relat Res. 2000 May;(374):298-302, 317-9.
Peng JJ. Medical theory on orthopedics combining molecular imaging with clinical practice. In: Derbel F. Soft tissue tumors. 2011. Available from:
Al-Shammari AM, Elgazzar AH, Ashkanani RA. 99mTc-MIBI whole body scan: A potentially useful technique for evaluating metabolic bone disease. World J Nucl Med.2013;12(1):8-13.
Bergson EJ, Sznyter LA, Dubner S, Palestro CJ, Heller KS. Sestamibi scans and intraoperative parathyroid hormone measurement in the treatment of primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg. 2004 Jan;130(1):87-91.
Gotway MB, Leung JW, Gooding GA, Litt HI, Reddy GP, Morita ET, Webb WR, Clark OH, Higgins CB. Hyperfunctioning parathyroid tissue: spectrum of appearances on noninvasive imaging. AJR Am J Roentgenol. 2002 Aug;179(2):495-502.
Airaghi L, Pisano G, Pulixi E, Benti R, Baldini M. Unusual presentation in a case of primary hyperparathyroidism. J Res Med Sci. 2011 Aug;16(8):1078-81.
Caldarella C, Treglia G, Isgrò MA, Giordano A. Diagnostic performance of positron emission tomography using ¹¹C-methionine in patients with suspected parathyroid adenoma: a meta-analysis. Endocrine. 2013 Feb;43(1):78-83.
Judenhofer MS, Wehrl HF, Newport DF, Catana C, Siegel SB, Becker M, Thielscher A, Kneilling M, Lichy MP, Eichner M, Klingel K, Reischl G, Widmaier S, Röcken M, Nutt RE, Machulla HJ, Uludag K, Cherry SR, Claussen CD, Pichler BJ. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med. 2008 Apr;14(4):459-65.
Lee SL, Steenkamp D. Expansile, lytic and hypermetabolic bone lesions not always metastatic cancer. Endocrine Today, June 2012. Available from: